Seeing Is Believing
Currently out of the existing stock ratings of Rachel Vatnsdal, 34 are a HOLD (41.98%), 41 are a BUY (50.62%), 6 are a SELL (7.41%).
Analyst Rachel Vatnsdal, currently employed at JPMORGAN, carries an average stock price target met ratio of 75.74% that have a potential upside of 18.88% achieved within 161 days.
Rachel Vatnsdal’s has documented 156 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RVTY, Revvity at 02-Feb-2026.
Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for TEM (TEMPUS AI, COMMON STOCK) at 8/7/2024. The price target of $47 was fulfilled within 8 days with a profit of $8.18 (21.07%) receiving and performance score of 26.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.65
$0.51 (364.29%)
$3.35
3 years 2 months 12 days ago
(18-May-2023)
2/2 (100%)
$0.06 (10.17%)
10
Buy
$1.25
$1.2 (2400.00%)
$19
3 years 2 months 20 days ago
(10-May-2023)
3/4 (75%)
$2.13 (47.39%)
21
Buy
$5
$4.86 (3471.43%)
$30
3 years 4 months 14 days ago
(16-Mar-2023)
7/10 (70%)
$3.68 (278.79%)
819
Hold
$2
$1.86 (1328.57%)
$2.5
3 years 6 months 27 days ago
(03-Jan-2023)
1/2 (50%)
$0.55 (37.93%)
2
Hold
3 years 8 months 21 days ago
(09-Nov-2022)
1/2 (50%)
$7.57 (43.43%)
391
Which stock is Rachel Vatnsdal is most bullish on?
What Year was the first public recommendation made by Rachel Vatnsdal?